JP2015105266A - アレルゲン抗体およびそれを有する組成物と抗体を有するフィルター - Google Patents
アレルゲン抗体およびそれを有する組成物と抗体を有するフィルター Download PDFInfo
- Publication number
- JP2015105266A JP2015105266A JP2013249674A JP2013249674A JP2015105266A JP 2015105266 A JP2015105266 A JP 2015105266A JP 2013249674 A JP2013249674 A JP 2013249674A JP 2013249674 A JP2013249674 A JP 2013249674A JP 2015105266 A JP2015105266 A JP 2015105266A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- allergen
- allergens
- antigen
- house dust
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000000427 antigen Substances 0.000 claims abstract description 31
- 102000036639 antigens Human genes 0.000 claims abstract description 31
- 108091007433 antigens Proteins 0.000 claims abstract description 31
- 239000000428 dust Substances 0.000 claims abstract description 23
- 235000013601 eggs Nutrition 0.000 claims abstract description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 20
- 241000271566 Aves Species 0.000 claims description 12
- 241000282326 Felis catus Species 0.000 abstract description 9
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 230000007815 allergy Effects 0.000 abstract description 4
- 210000002969 egg yolk Anatomy 0.000 description 31
- 235000013345 egg yolk Nutrition 0.000 description 28
- 102000002322 Egg Proteins Human genes 0.000 description 25
- 108010000912 Egg Proteins Proteins 0.000 description 25
- 241000287828 Gallus gallus Species 0.000 description 21
- 241000286209 Phasianidae Species 0.000 description 21
- 235000013330 chicken meat Nutrition 0.000 description 21
- 230000003053 immunization Effects 0.000 description 20
- 241000271567 Struthioniformes Species 0.000 description 19
- 241000272534 Struthio camelus Species 0.000 description 15
- 238000002965 ELISA Methods 0.000 description 14
- 238000002649 immunization Methods 0.000 description 13
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 11
- 102000004201 Ceramidases Human genes 0.000 description 11
- 108090000751 Ceramidases Proteins 0.000 description 11
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 11
- 229940106189 ceramide Drugs 0.000 description 11
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 11
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 11
- 230000009257 reactivity Effects 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000013573 pollen allergen Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 208000035533 House dust allergy Diseases 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010030111 Oedema mucosal Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
ダニアレルゲンに対する抗体を以下のようにし作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。ダニアレルゲン(Dfb,Dpb,Dff,Dpf)50μgをフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。
ハウスダストに対する抗体を以下のようにして作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。ハウスダストアレルゲン50μgをフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。なお、ここでハウスダストアレルゲンとは、生活空間から採取されたアレルゲンと考えられる物質の集合である。
ハウスダストアレルゲンを抗原として得た卵黄抗体の効果を調べた。ハウスダストアレルゲンを染み込ませて乾燥したディスク濾紙(1ディスク中5μgのアレルゲンを含有)(商品名:アレルゲンディスク「トリイ」ハウスダスト)に5μLのPBS(リン酸緩衝液)、または5μLのダチョウ卵黄抗体(ダニアレルゲンDfbまたはハウスダストアレルゲンを免疫して作製したもの)(15mg/mL)を添加し、室温で10分間放置した。その後、ディスク濾紙をハウスダストアレルギー罹患ボランティアの下鼻甲介粘膜に付け、5分間放置し、臨床症状(鼻内掻痒感、くしゃみ、水性鼻漏、粘膜腫脹)の有無を観察し、臨床症状の症状別の発現率を算出した。結果を表3に示す。
緑膿菌ホモジネート液を抗原とした抗体を以下のように作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。緑膿菌のホモジネート液(蛋白量50μg)をフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。
Claims (5)
- ハウスダストに係る複数のアレルゲンを抗原として鳥類の雌に接種させ、前記鳥類の雌が産んだ卵から精製した抗体。
- 請求項1に記載の抗体を含む組成物。
- 緑膿菌ホモジネート液を抗原として鳥類の雌に接種させ、前記鳥類の雌が産んだ卵から精製した抗体。
- 請求項3に記載の抗体を含む組成物。
- 請求項1に記載の抗体を有するフィルター。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013249674A JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013249674A JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017243883A Division JP6586450B2 (ja) | 2017-12-20 | 2017-12-20 | アレルゲン抗体およびそれを有する組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015105266A true JP2015105266A (ja) | 2015-06-08 |
JP6529216B2 JP6529216B2 (ja) | 2019-06-12 |
Family
ID=53435612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013249674A Active JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6529216B2 (ja) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0920684A (ja) * | 1995-07-07 | 1997-01-21 | Lotte Co Ltd | チューインガム |
JP2009155520A (ja) * | 2007-12-27 | 2009-07-16 | Kao Corp | アレルゲン不活化剤 |
JP2012107253A (ja) * | 2012-02-14 | 2012-06-07 | Fumakilla Ltd | アレルゲン失活剤 |
JP2012144635A (ja) * | 2011-01-12 | 2012-08-02 | Sumika Enviro-Science Co Ltd | 抗アレルゲン組成物 |
JP2013147471A (ja) * | 2012-01-23 | 2013-08-01 | Venture Bank Inc | ダチョウ抗体水溶液 |
JP2013163662A (ja) * | 2012-02-10 | 2013-08-22 | Ostrich Pharma Kk | 抗体含有花粉アレルギー防御素材 |
-
2013
- 2013-12-02 JP JP2013249674A patent/JP6529216B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0920684A (ja) * | 1995-07-07 | 1997-01-21 | Lotte Co Ltd | チューインガム |
JP2009155520A (ja) * | 2007-12-27 | 2009-07-16 | Kao Corp | アレルゲン不活化剤 |
JP2012144635A (ja) * | 2011-01-12 | 2012-08-02 | Sumika Enviro-Science Co Ltd | 抗アレルゲン組成物 |
JP2013147471A (ja) * | 2012-01-23 | 2013-08-01 | Venture Bank Inc | ダチョウ抗体水溶液 |
JP2013163662A (ja) * | 2012-02-10 | 2013-08-22 | Ostrich Pharma Kk | 抗体含有花粉アレルギー防御素材 |
JP2012107253A (ja) * | 2012-02-14 | 2012-06-07 | Fumakilla Ltd | アレルゲン失活剤 |
Non-Patent Citations (1)
Title |
---|
塚本 康浩 YASUHIRO TSUKAMOTO YASUHIRO TSUKAMOTO: "ダチョウ抗体を用いた新規機能性化粧品の開発 Development of functional skin-care products using", フレグランスジャーナル 6月号, vol. 第41巻, JPN6017030141, ISSN: 0003721000 * |
Also Published As
Publication number | Publication date |
---|---|
JP6529216B2 (ja) | 2019-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | A review on human health perspective of air pollution with respect to allergies and asthma | |
Fernández et al. | Indoor air contaminants and their impact on respiratory pathologies | |
Kanchongkittiphon et al. | The indoor environment and inner-city childhood asthma | |
Esty et al. | Asthma and allergies in the school environment | |
Sundman et al. | Signs of sinusitis in times of urbanization in Viking Age-Early Medieval Sweden | |
Tauer‐Reich et al. | Allergens causing bird fancier's asthma | |
Liccardi et al. | Avoidance of allergens and air pollutants in respiratory allergy | |
JP6586450B2 (ja) | アレルゲン抗体およびそれを有する組成物 | |
Luo et al. | Effect of enriched housing on levels of natural (auto-) antibodies in pigs co-infected with porcine reproductive and respiratory syndrome virus (PRRSV) and Actinobacillus pleuropneumoniae | |
Kilpiö et al. | Allergy to feathers | |
Platts-Mills | Allergen avoidance in the treatment of asthma and allergic rhinitis | |
JP6529216B2 (ja) | ハウスダストによるくしゃみ抑制用組成物 | |
KR101085540B1 (ko) | 여드름균에 대한 항체를 지닌 난황을 함유하는 여드름 개선용 화장료 조성물 | |
JP2017006008A (ja) | Mers用抗体および抗血清 | |
UA72734C2 (en) | Vaseline-based nasal ointment for preventing inhalation allergic reactions | |
Gabanakgosi et al. | Ethnoveterinary medicine usage in family chickens in the selected four villages of Botswana | |
CN114470198B (zh) | 一种用于防治新冠肺炎的SARS-CoV-2卵黄中和抗体IgY喷雾剂 | |
Banzon et al. | Environmental interventions for asthma | |
Sybilski et al. | The effects of disease awareness on lifestyle changes and the use of preventive measures in asthma patients. | |
Ho et al. | Respiratory health in home and leisure pursuits | |
Tsukamoto et al. | Ostrich antibody and its application to skin diseases, a review and case report | |
JP6200630B2 (ja) | 医薬組成物 | |
Okiki et al. | Effects of air-borne hazards on the physical and psychological health of nigerian poultry workers | |
Bergmann et al. | The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge | |
Obol et al. | Possession, attitudes and perceptions of insecticide-treated bed nets among pregnant women in a post conflict district in Northern Uganda |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170822 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171220 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180123 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190315 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190514 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6529216 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |